51 days until earnings call
Interact to see
Advertisement
Advertisement
FICS vs GSK
FICS vs GSK Comparison
Open Charts FICS vs GSK
First Trust Intl Developed Cap Strth ETF
Price$39.13
Change+$0.16 (+0.41%)
Volume$638
Net Assets227.34M
FICS vs GSK Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
FICS vs. GSK commentary
Sep 08, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FICS is a Hold and GSK is a StrongBuy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 62 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| FICS | GSK | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 44% |
| Stochastic ODDS (%) | 4 days ago 87% | 4 days ago 46% |
| Momentum ODDS (%) | 4 days ago 79% | 4 days ago 67% |
| MACD ODDS (%) | 4 days ago 77% | 4 days ago 71% |
| TrendWeek ODDS (%) | 4 days ago 81% | 4 days ago 60% |
| TrendMonth ODDS (%) | 4 days ago 77% | 4 days ago 53% |
| Advances ODDS (%) | 4 days ago 82% | 4 days ago 59% |
| Declines ODDS (%) | 7 days ago 81% | N/A |
| BollingerBands ODDS (%) | 4 days ago 90% | 4 days ago 51% |
| Aroon ODDS (%) | N/A | 4 days ago 44% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| APDDX | 23.39 | 0.40 | +1.74% |
| Artisan Global Discovery Advisor | |||
| TIGAX | 25.36 | 0.16 | +0.63% |
| Thornburg International Growth A | |||
| LBRIX | 31.37 | -0.01 | -0.03% |
| ClearBridge Dividend Strategy FI | |||
| IBNYX | 25.49 | -0.01 | -0.04% |
| Macquarie Balanced Fund Class Y | |||
| RLSFX | 14.80 | -0.05 | -0.34% |
| RiverPark Long/Short Opportunity Retail | |||
FICS and
Correlation & Price change
A.I.dvisor indicates that over the last year, FICS has been loosely correlated with GSK. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FICS jumps, then GSK could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To FICS | 1D Price Change % | ||
|---|---|---|---|---|
| FICS | 100% | +0.70% | ||
| GSK - FICS | 46% Loosely correlated | +2.25% | ||
| AZN - FICS | 41% Loosely correlated | -0.10% | ||
| RIO - FICS | 40% Loosely correlated | +2.42% | ||
| ALV - FICS | 39% Loosely correlated | +0.09% | ||
| TRI - FICS | 39% Loosely correlated | -2.31% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with AZN. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then AZN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y